Skip to content

DBVT

DBV Technologies SA

NASDAQ · Healthcare · Biotechnology · FR

$9.94
−1.68%
Ask drillr

Next report

Analyst consensus

Next report date
Mar 25, 2027
EPS estimate
-$0.75
Revenue estimate
$494.0K

Latest reported

Last report date
Oct 28, 2026
EPS actual
-$0.70
EPS estimate
-$0.60
Revenue actual
$1.8M
Revenue estimate
$558.2K

Track record

Trailing twelve quarters

EPS beats (12Q)
6
EPS misses (12Q)
5
EPS in line (12Q)
1
Avg surprise (4Q)
-79.9%
Revenue beats (12Q)
6

Analyst ratings

Sell-side consensus

Consensus
Buy
Price target
$47
PT range
$46 – $47
Analysts
2
2 Buy0 Hold0 Sell
Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Oct 28, 2026-$0.60-$0.70Miss -16.67%$1.8M
Jul 16, 2026-$0.12-$0.14Miss -14.32%$800.2K
Apr 30, 2026-$0.14-$0.56Miss -300.00%$1.1M
Mar 26, 2026-$1.30-$1.15Beat 11.54%$577.6K
Oct 28, 2025-$1.45-$1.20Beat 17.24%$3.2M
Jul 29, 2025-$0.21-$1.55Miss -638.10%$1.7M
Apr 30, 2025-$0.24-$0.26Miss -8.33%$906.4K
Mar 27, 2025-$2.00-$1.20Beat 40.00%$553.1K
Mar 7, 2024-$0.32-$0.12Beat 62.50%$2.4M
May 4, 2023-$0.50-$0.22Beat 56.00%$2.4M
Mar 2, 2023-$2.30-$2.30In line-$1.4M
Nov 3, 2022-$0.32-$0.18Beat 43.75%$2.0M

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 25, 2027